Narrow search
Showing 1 - 10 of 5,409
Cover Image
An empirical model of drug detailing : dynamic competition and policy implications
Liu, Qiang; Gupta, Sachin; Venkataraman, Sriram; Liu, Hongju - In: Management science : journal of the Institute for … 62 (2016) 8, pp. 2321-2340
Persistent link: https://www.econbiz.de/10011539516
Cover Image
Regulation and competition in the Taiwanese pharmaceutical market under national health insurance
Liu, Ya Ming; Yea-huei Kao Yang; Hsieh, Chee-Ruey - In: Journal of health economics 31 (2012) 3, pp. 471-483
Persistent link: https://www.econbiz.de/10009625666
Cover Image
An empirical model of drug pricing and competition : a dynamic perspective
Camejo, Rodrigo Refoios; McGrath, Clare; Rutten, F. F. H. - In: International journal of economics and business research 6 (2013) 2, pp. 173-193
Persistent link: https://www.econbiz.de/10010351165
Cover Image
A ban on "private label" generic pharmaceuticals : legal and economic context
Anis, Aslam H.; Harvard, Stephanie - In: International journal of the economics of business 22 (2015) 2, pp. 219-229
Persistent link: https://www.econbiz.de/10011405945
Cover Image
Manufacturing and Regulatory Barriers to Generic Drug Competition : A Structural Model Approach
Wang, Yixin (Iris) - 2020
Understanding the drivers of market concentration in the generic pharmaceutical industry is essential to guaranteeing the availability of low-cost generics. In this paper, we develop a structural model to capture the multiple determinants governing manufacturers' entry decisions; in particular,...
Persistent link: https://www.econbiz.de/10012852626
Cover Image
Competition, regulation, and entry timing in marketing for pharmaceutical line extensions
Kina, Samuel H. - 2011
Persistent link: https://www.econbiz.de/10011949716
Cover Image
Does Regulation Drive Out Competition in Pharmaceutical Markets?
Danzon, Patricia M.; Chao, Li-Wei - 2011
best weak in this industry. This paper tests the hypothesis that regulation of manufacturer prices and of retail pharmacy … markets (US, UK, Canada, Germany) but that regulation undermines generic competition in strict regulatory systems (France …, Italy, Japan). Regulation of retail pharmacy further constrains competition in France, Germany and Italy. Regulation thus …
Persistent link: https://www.econbiz.de/10014038394
Cover Image
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona; Stern, Ariel D.; Stern, Scott - 2017
Persistent link: https://www.econbiz.de/10011708133
Cover Image
The impact of R&D cooperations on drug variety offered on the market : evidence from the pharmaceutical industry
Banerjee, Tannista; Siebert, Ralph - 2014
Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...
Persistent link: https://www.econbiz.de/10010229875
Cover Image
Reforming the Swedish pharmaceuticals market : consequences for costs per defined daily dose
Bergman, Mats A.; Granlund, David; Rudholm, Niklas - In: International journal of health economics and management 16 (2016) 3, pp. 201-214
Persistent link: https://www.econbiz.de/10011811445